| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.732 | 0.001 | 0.732 | Catechol O-methyltransferase inhibitor | 0.157 0.004 CID_154699618 | ||
| 0.698 | 0.034 | 0.883 | Alpha-glucosidase inhibitor | 0.883 0.009 CID_154699618 | CID_154699618 | |
| 0.603 | 0.005 | 0.603 | Calcium channel L-type activator | 0.488 0.032 CID_154699618 | ||
| 0.548 | 0.017 | 0.548 | 12-Lipoxygenase inhibitor | |||
| 0.544 | 0.027 | 0.544 | Aldehyde oxidase inhibitor | |||
| 0.575 | 0.065 | 0.575 | DNA polymerase beta inhibitor | |||
| 0.514 | 0.005 | 0.514 | Mcl-1 antagonist | 0.166 0.076 CID_154699618 | ||
| 0.568 | 0.064 | 0.568 | DNA directed DNA polymerase inhibitor | 0.275 0.176 CID_154699618 | ||
| 0.51 | 0.007 | 0.51 | Dual specificity phosphatase 3 inhibitor | 0.146 0.099 CID_154699618 | ||
| 0.514 | 0.018 | 0.514 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.485 | 0.006 | 0.485 | Calcium channel activator | 0.296 0.096 CID_154699618 | ||
| 0.516 | 0.038 | 0.516 | Prostaglandin dehydrogenase inhibitor | |||
| 0.487 | 0.017 | 0.655 | Free radical scavenger | 0.655 0.006 CID_154699618 | CID_154699618 | |
| 0.472 | 0.016 | 0.472 | Superoxide dismutase inhibitor | |||
| 0.464 | 0.008 | 0.464 | Dual specificity phosphatase inhibitor | |||
| 0.439 | 0.01 | 0.439 | Tubulin antagonist | 0.129 0.072 CID_154699618 | ||
| 0.457 | 0.035 | 0.457 | Streptokinase A inhibitor | |||
| 0.491 | 0.077 | 0.638 | Apoptosis agonist | 0.638 0.042 CID_154699618 | CID_154699618 | |
| 0.437 | 0.029 | 0.672 | Antioxidant | 0.672 0.007 CID_154699618 | CID_154699618 | |
| 0.406 | 0.009 | 0.758 | Amylase inhibitor | 0.758 0.002 CID_154699618 | CID_154699618 | |
| 0.438 | 0.043 | 0.438 | Thioredoxin glutathione reductase inhibitor | |||
| 0.442 | 0.054 | 0.742 | Transcription factor NF kappa B inhibitor | 0.742 0.017 CID_154699618 | CID_154699618 | |
| 0.391 | 0.004 | 0.391 | Alcohol dehydrogenase inhibitor | 0.293 0.005 CID_154699618 | ||
| 0.385 | 0.005 | 0.385 | M18 aspartyl aminopeptidase inhibitor | 0.137 0.059 CID_154699618 | ||
| 0.384 | 0.01 | 0.4 | Lipid peroxidase inhibitor | 0.4 0.009 CID_154699618 | CID_154699618 | |
| 0.458 | 0.088 | 0.458 | Transcription factor inhibitor | |||
| 0.451 | 0.083 | 0.491 | Caspase 9 stimulant | 0.491 0.063 CID_154699618 | CID_154699618 | |
| 0.366 | 0.004 | 0.383 | Mannose-6-phosphate isomerase inhibitor | 0.383 0.003 CID_154699618 | CID_154699618 | |
| 0.364 | 0.006 | 0.364 | NADPH oxidase inhibitor | 0.291 0.014 CID_154699618 | ||
| 0.351 | 0.005 | 0.504 | Xanthine oxidase inhibitor | 0.504 0.004 CID_154699618 | CID_154699618 | |
| 0.384 | 0.041 | 0.633 | Vasodilator, coronary | 0.633 0.006 CID_154699618 | CID_154699618 | |
| 0.374 | 0.036 | 0.476 | Interleukin 2 agonist | 0.476 0.011 CID_154699618 | CID_154699618 | |
| 0.376 | 0.042 | 0.376 | Aryl hydrocarbon receptor agonist | |||
| 0.361 | 0.03 | 0.361 | Pyruvate kinase inhibitor | |||
| 0.324 | 0.002 | 0.324 | DOPA decarboxylase inhibitor | 0.122 0.042 CID_154699618 | ||
| 0.387 | 0.068 | 0.387 | Calpain 2 inhibitor | |||
| 0.334 | 0.017 | 0.43 | DNA methyltransferase I inhibitor | 0.43 0.007 CID_154699618 | CID_154699618 | |
| 0.349 | 0.032 | 0.349 | Antimitotic | 0.159 0.113 CID_154699618 | ||
| 0.379 | 0.062 | 0.396 | Vasodilator, peripheral | 0.396 0.056 CID_154699618 | CID_154699618 | |
| 0.366 | 0.068 | 0.366 | Thyroid hormone antagonist | |||
| 0.348 | 0.051 | 0.348 | Lipoxygenase inhibitor | |||
| 0.356 | 0.062 | 0.642 | Cholesterol antagonist | 0.642 0.013 CID_154699618 | CID_154699618 | |
| 0.296 | 0.006 | 0.296 | Farnesoid X receptor antagonist | 0.164 0.039 CID_154699618 | ||
| 0.299 | 0.01 | 0.299 | Heat shock protein 90 antagonist | |||
| 0.337 | 0.049 | 0.345 | Hypoxia-inducible factor 1 alpha inhibitor | 0.345 0.047 CID_154699618 | CID_154699618 | |
| 0.31 | 0.025 | 0.424 | DNA methylase inhibitor | 0.424 0.009 CID_154699618 | CID_154699618 | |
| 0.293 | 0.013 | 0.317 | Nitric-oxide synthase stimulant | 0.317 0.008 CID_154699618 | CID_154699618 | |
| 0.293 | 0.015 | 0.293 | Heat shock protein 90 alpha antagonist | |||
| 0.3 | 0.024 | 0.3 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.178 0.095 CID_154699618 | ||
| 0.306 | 0.03 | 0.306 | RNA-directed DNA polymerase inhibitor | 0.278 0.037 CID_154699618 | ||
| 0.344 | 0.071 | 0.344 | Thyroid hormone beta antagonist | |||
| 0.313 | 0.042 | 0.459 | Interleukin agonist | 0.459 0.012 CID_154699618 | CID_154699618 | |
| 0.293 | 0.037 | 0.293 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.256 | 0.005 | 0.256 | Alpha tubulin antagonist | 0.054 0.036 CID_154699618 | ||
| 0.302 | 0.057 | 0.302 | Insulysin inhibitor | |||
| 0.258 | 0.023 | 0.258 | Histone acetyltransferase inhibitor | |||
| 0.284 | 0.048 | 0.284 | Amyloid beta aggregation inhibitor | 0.181 0.088 CID_154699618 | ||
| 0.255 | 0.021 | 0.255 | Succinate dehydrogenase inhibitor | |||
| 0.238 | 0.006 | 0.238 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.244 | 0.014 | 0.433 | UDP-glucose 4-epimerase inhibitor | 0.433 0.004 CID_154699618 | CID_154699618 | |
| 0.237 | 0.008 | 0.237 | Uric acid excretion stimulant | 0.232 0.009 CID_154699618 | ||
| 0.251 | 0.024 | 0.606 | Monophenol monooxygenase inhibitor | 0.606 0.005 CID_154699618 | CID_154699618 | |
| 0.242 | 0.018 | 0.242 | Chelator | |||
| 0.222 | 0.01 | 0.222 | Porphobilinogen synthase inhibitor | |||
| 0.217 | 0.008 | 0.217 | Creatine kinase inhibitor | |||
| 0.212 | 0.004 | 0.212 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.322 | 0.117 | 0.322 | 15-Lipoxygenase inhibitor | |||
| 0.212 | 0.009 | 0.212 | HIV-1 integrase (Strand Transfer) inhibitor | 0.107 0.02 CID_154699618 | ||
| 0.25 | 0.047 | 0.25 | Peroxidase inhibitor | |||
| 0.225 | 0.025 | 0.271 | Alkaline phosphatase inhibitor | 0.271 0.016 CID_154699618 | CID_154699618 | |
| 0.207 | 0.008 | 0.207 | Thioredoxin inhibitor | 0.206 0.008 CID_154699618 | ||
| 0.208 | 0.01 | 0.368 | Triose-phosphate isomerase inhibitor | 0.368 0.004 CID_154699618 | CID_154699618 | |
| 0.243 | 0.046 | 0.499 | Non-steroidal antiinflammatory agent | 0.499 0.007 CID_154699618 | CID_154699618 | |
| 0.225 | 0.029 | 0.287 | Interleukin 6 antagonist | 0.287 0.017 CID_154699618 | CID_154699618 | |
| 0.2 | 0.008 | 0.2 | Beta tubulin antagonist | |||
| 0.229 | 0.037 | 0.229 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.2 | 0.01 | 0.2 | HIV-1 integrase (3'-Processing) inhibitor | 0.111 0.022 CID_154699618 | ||
| 0.203 | 0.014 | 0.203 | Adenylate kinase inhibitor | 0.142 0.03 CID_154699618 | ||
| 0.257 | 0.073 | 0.62 | Hypoglycemic | 0.62 0.007 CID_154699618 | CID_154699618 | |
| 0.211 | 0.028 | 0.211 | Interleukin 1 antagonist | 0.115 0.096 CID_154699618 | ||
| 0.201 | 0.022 | 0.201 | Interleukin 4 antagonist | 0.198 0.023 CID_154699618 | ||
| 0.209 | 0.039 | 0.209 | Phospholipase C inhibitor | 0.181 0.06 CID_154699618 | ||
| 0.242 | 0.074 | 0.301 | Antiamyloidogenic | 0.301 0.051 CID_154699618 | CID_154699618 | |
| 0.2 | 0.033 | 0.2 | Arachidonic acid antagonist | 0.125 0.119 CID_154699618 | ||
| 0.3 | 0.135 | 0.656 | Antibacterial | 0.656 0.012 CID_154699618 | CID_154699618 | |
| 0.18 | 0.019 | 0.18 | Interleukin 8 antagonist | |||
| 0.196 | 0.036 | 0.196 | Cyclooxygenase 1 inhibitor | 0.145 0.059 CID_154699618 | ||
| 0.177 | 0.017 | 0.177 | Breast cancer-resistant protein inhibitor | |||
| 0.175 | 0.017 | 0.6 | Beta glucuronidase inhibitor | 0.6 0.003 CID_154699618 | CID_154699618 | |
| 0.196 | 0.041 | 0.351 | ATPase inhibitor | 0.351 0.004 CID_154699618 | CID_154699618 | |
| 0.172 | 0.018 | 0.172 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.168 | 0.017 | 0.168 | Histidine decarboxylase inhibitor | |||
| 0.176 | 0.026 | 0.176 | Interleukin 1b antagonist | 0.129 0.055 CID_154699618 | ||
| 0.179 | 0.029 | 0.179 | 5-Lipoxygenase inhibitor | |||
| 0.19 | 0.041 | 0.347 | Hexokinase inhibitor | 0.347 0.006 CID_154699618 | CID_154699618 | |
| 0.19 | 0.045 | 0.364 | Interferon gamma antagonist | 0.364 0.013 CID_154699618 | CID_154699618 | |
| 0.163 | 0.018 | 0.163 | Carbonic anhydrase VI inhibitor | 0.103 0.037 CID_154699618 | ||
| 0.153 | 0.011 | 0.153 | Glutathione S-transferase inhibitor | 0.095 0.042 CID_154699618 | ||
| 0.164 | 0.023 | 0.209 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.209 0.014 CID_154699618 | CID_154699618 | |
| 0.209 | 0.068 | 0.234 | Neurotrophic factor enhancer | 0.234 0.048 CID_154699618 | CID_154699618 | |
| 0.186 | 0.047 | 0.383 | Melanin inhibitor | 0.383 0.013 CID_154699618 | CID_154699618 | |
| 0.177 | 0.039 | 0.177 | CF transmembrane conductance regulator agonist | 0.132 0.113 CID_154699618 | ||
| 0.234 | 0.099 | 0.234 | Gastrin inhibitor | |||
| 0.16 | 0.025 | 0.16 | TRPA1 agonist | 0.122 0.056 CID_154699618 | ||
| 0.186 | 0.051 | 0.186 | Phospholipase A2 inhibitor | 0.143 0.083 CID_154699618 | ||
| 0.187 | 0.052 | 0.187 | Protein-tyrosine phosphatase inhibitor | 0.169 0.063 CID_154699618 | ||
| 0.142 | 0.008 | 0.146 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.146 0.008 CID_154699618 | CID_154699618 | |
| 0.224 | 0.09 | 0.224 | Calpain inhibitor | |||
| 0.152 | 0.018 | 0.152 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.153 | 0.022 | 0.153 | Androgen antagonist | |||
| 0.23 | 0.103 | 0.23 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.134 | 0.009 | 0.134 | Xanthine dehydrogenase inhibitor | 0.062 0.037 CID_154699618 | ||
| 0.161 | 0.038 | 0.161 | Antibacterial (Helicobacter pylori) | 0.111 0.096 CID_154699618 | ||
| 0.146 | 0.025 | 0.146 | Urease inhibitor | |||
| 0.265 | 0.144 | 0.467 | Histamine release inhibitor | 0.467 0.042 CID_154699618 | CID_154699618 | |
| 0.149 | 0.029 | 0.149 | Carbonic anhydrase III inhibitor | 0.111 0.051 CID_154699618 | ||
| 0.15 | 0.031 | 0.226 | Photosensitizer | 0.226 0.009 CID_154699618 | CID_154699618 | |
| 0.13 | 0.013 | 0.13 | Bile acid receptor antagonist | 0.095 0.06 CID_154699618 | ||
| 0.17 | 0.056 | 0.17 | Cyclooxygenase inhibitor | 0.133 0.085 CID_154699618 | ||
| 0.129 | 0.017 | 0.129 | Prostaglandin-E synthase inhibitor | |||
| 0.126 | 0.013 | 0.126 | Biliverdin reductase inhibitor | 0.07 0.032 CID_154699618 | ||
| 0.132 | 0.022 | 0.132 | Estrogen receptor beta antagonist | |||
| 0.181 | 0.072 | 0.181 | Amyloid beta precursor protein antagonist | |||
| 0.214 | 0.105 | 0.286 | DNA damaging | 0.286 0.063 CID_154699618 | CID_154699618 | |
| 0.207 | 0.099 | 0.385 | Vasodilator | 0.385 0.026 CID_154699618 | CID_154699618 | |
| 0.122 | 0.016 | 0.122 | Thioredoxin reductase inhibitor | 0.085 0.049 CID_154699618 | ||
| 0.125 | 0.019 | 0.125 | Glutamate decarboxylase inhibitor | |||
| 0.19 | 0.085 | 0.19 | Insulin sensitizer | 0.178 0.098 CID_154699618 | ||
| 0.136 | 0.031 | 0.136 | Estrogen antagonist | 0.103 0.09 CID_154699618 | ||
| 0.109 | 0.004 | 0.109 | Dihydroorotate oxidase inhibitor | |||
| 0.147 | 0.042 | 0.147 | Cystathionine beta-synthase inhibitor | 0.137 0.047 CID_154699618 | ||
| 0.108 | 0.005 | 0.108 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.112 | 0.01 | 0.112 | Transcription factor AP-1 inhibitor | 0.084 0.019 CID_154699618 | ||
| 0.152 | 0.05 | 0.152 | Pregnane X receptor agonist | |||
| 0.148 | 0.046 | 0.148 | Ca2+-transporting ATPase inhibitor | 0.145 0.058 CID_154699618 | ||
| 0.239 | 0.139 | 0.47 | Apoptosis antagonist | 0.47 0.024 CID_154699618 | CID_154699618 | |
| 0.115 | 0.016 | 0.115 | D-Ala-D-Ala ligase inhibitor | |||
| 0.151 | 0.052 | 0.151 | Toll-Like receptor 2 antagonist | |||
| 0.113 | 0.015 | 0.113 | Alcohol oxidase inhibitor | |||
| 0.114 | 0.018 | 0.114 | HIV-1 integrase inhibitor | |||
| 0.214 | 0.117 | 0.214 | Transcription factor STAT3 inhibitor | |||
| 0.143 | 0.051 | 0.157 | Aldehyde dehydrogenase inhibitor | 0.157 0.044 CID_154699618 | CID_154699618 | |
| 0.137 | 0.045 | 0.258 | DNA repair enzyme inhibitor | 0.258 0.005 CID_154699618 | CID_154699618 | |
| 0.144 | 0.053 | 0.183 | DNA polymerase I inhibitor | 0.183 0.034 CID_154699618 | CID_154699618 | |
| 0.12 | 0.029 | 0.145 | Interleukin 12 antagonist | 0.145 0.014 CID_154699618 | CID_154699618 | |
| 0.21 | 0.119 | 0.21 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.174 | 0.085 | 0.189 | P-glycoprotein inhibitor | 0.189 0.072 CID_154699618 | CID_154699618 | |
| 0.103 | 0.015 | 0.103 | GABA B receptor agonist | |||
| 0.095 | 0.008 | 0.095 | Transcription factor RelA inhibitor | |||
| 0.14 | 0.054 | 0.14 | Cathepsin H inhibitor | |||
| 0.144 | 0.059 | 0.223 | Alpha-N-acetylglucosaminidase inhibitor | 0.223 0.028 CID_154699618 | CID_154699618 | |
| 0.186 | 0.102 | 0.716 | Angiogenesis stimulant | 0.716 0.004 CID_154699618 | CID_154699618 | |
| 0.087 | 0.004 | 0.087 | Glutamate (mGluR8) agonist | |||
| 0.107 | 0.024 | 0.107 | CDC25A inhibitor | |||
| 0.163 | 0.08 | 0.163 | Death-associated protein kinase 2 inhibitor | |||
| 0.243 | 0.16 | 0.243 | GABA C receptor rho-3 antagonist | |||
| 0.132 | 0.049 | 0.18 | Microtubule formation inhibitor | 0.18 0.025 CID_154699618 | CID_154699618 | |
| 0.222 | 0.14 | 0.32 | Caspase 3 stimulant | 0.32 0.07 CID_154699618 | CID_154699618 | |
| 0.147 | 0.067 | 0.147 | MAP kinase kinase 4 inhibitor | |||
| 0.098 | 0.018 | 0.098 | Maillard reaction inhibitor | 0.065 0.032 CID_154699618 | ||
| 0.098 | 0.019 | 0.098 | Bcl2 antagonist | |||
| 0.104 | 0.029 | 0.104 | HIV-1 reverse transcriptase inhibitor | |||
| 0.145 | 0.07 | 0.145 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.093 | 0.019 | 0.093 | Purinergic P2X1 antagonist | |||
| 0.1 | 0.027 | 0.1 | GABA aminotransferase inhibitor | 0.093 0.032 CID_154699618 | ||
| 0.157 | 0.085 | 0.157 | Neurotensin receptor agonist | |||
| 0.099 | 0.027 | 0.099 | Estrogen receptor alpha antagonist | |||
| 0.12 | 0.048 | 0.148 | Multidrug resistance-associated protein 1 inhibitor | 0.148 0.026 CID_154699618 | CID_154699618 | |
| 0.087 | 0.015 | 0.087 | Fatty acid synthase inhibitor | |||
| 0.115 | 0.045 | 0.115 | Anabolic | |||
| 0.09 | 0.022 | 0.09 | NMDA receptor glycine site agonist | |||
| 0.093 | 0.025 | 0.093 | Glycine receptor agonist | 0.086 0.032 CID_154699618 | ||
| 0.146 | 0.078 | 0.146 | Cytidine deaminase inhibitor | |||
| 0.103 | 0.036 | 0.135 | ATPase (Vacuolar H+) inhibitor | 0.135 0.012 CID_154699618 | CID_154699618 | |
| 0.075 | 0.009 | 0.075 | Urate transporter 1 inhibitor | |||
| 0.079 | 0.013 | 0.079 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.185 | 0.12 | 0.391 | Peptidyltransferase inhibitor | 0.391 0.008 CID_154699618 | CID_154699618 | |
| 0.126 | 0.062 | 0.267 | Alkylator | 0.267 0.015 CID_154699618 | CID_154699618 | |
| 0.075 | 0.013 | 0.075 | CD45 antagonist | |||
| 0.124 | 0.064 | 0.124 | Adenylate cyclase inhibitor | |||
| 0.172 | 0.112 | 0.172 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.142 | 0.081 | 0.335 | NOS3 expression enhancer | 0.335 0.013 CID_154699618 | CID_154699618 | |
| 0.102 | 0.042 | 0.102 | Ornithine decarboxylase inhibitor | 0.076 0.071 CID_154699618 | ||
| 0.064 | 0.005 | 0.064 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.081 | 0.022 | 0.093 | Nitric oxide donor | 0.093 0.013 CID_154699618 | CID_154699618 | |
| 0.128 | 0.07 | 0.128 | Vanilloid 1 agonist | 0.127 0.071 CID_154699618 | ||
| 0.13 | 0.073 | 0.13 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.139 | 0.082 | 0.139 | Adenylate cyclase stimulant | |||
| 0.097 | 0.04 | 0.097 | Inducible nitric-oxide synthase inhibitor | |||
| 0.153 | 0.097 | 0.153 | Tumour necrosis factor antagonist | |||
| 0.102 | 0.046 | 0.102 | Potassium channel activator | |||
| 0.09 | 0.036 | 0.182 | Phosphofructokinase-1 inhibitor | 0.182 0.013 CID_154699618 | CID_154699618 | |
| 0.286 | 0.232 | 0.286 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.072 | 0.018 | 0.072 | Plasminogen activator inhibitor antagonist | |||
| 0.137 | 0.085 | 0.15 | Heat shock protein 70 antagonist | 0.15 0.045 CID_154699618 | CID_154699618 | |
| 0.089 | 0.038 | 0.089 | Glutamate dehydrogenase inhibitor | |||
| 0.076 | 0.026 | 0.076 | MDM2 inhibitor | |||
| 0.079 | 0.029 | 0.079 | CDC25B inhibitor | |||
| 0.116 | 0.066 | 0.144 | Protein-tyrosine phosphatase 1B inhibitor | 0.144 0.048 CID_154699618 | CID_154699618 | |
| 0.07 | 0.02 | 0.07 | Bcl-xL inhibitor | |||
| 0.131 | 0.082 | 0.272 | Protein kinase stimulant | 0.272 0.021 CID_154699618 | CID_154699618 | |
| 0.082 | 0.034 | 0.085 | Carbonic anhydrase inhibitor | 0.085 0.033 CID_154699618 | CID_154699618 | |
| 0.261 | 0.213 | 0.361 | 5 Hydroxytryptamine release inhibitor | 0.361 0.106 CID_154699618 | CID_154699618 | |
| 0.108 | 0.06 | 0.108 | Aminopeptidase B inhibitor | |||
| 0.146 | 0.099 | 0.409 | Nitric oxide antagonist | 0.409 0.025 CID_154699618 | CID_154699618 | |
| 0.089 | 0.043 | 0.089 | Estrogen-related receptor beta agonist | |||
| 0.055 | 0.011 | 0.055 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.133 | 0.091 | 0.133 | Thiol protease inhibitor | |||
| 0.099 | 0.057 | 0.099 | Potassium channel (Ca-activated) activator | |||
| 0.069 | 0.027 | 0.116 | Aldose reductase inhibitor | 0.116 0.015 CID_154699618 | CID_154699618 | |
| 0.068 | 0.027 | 0.068 | Botulinum neurotoxin type A inhibitor | |||
| 0.052 | 0.012 | 0.052 | Potassium channel Kv1.1 blocker | |||
| 0.072 | 0.033 | 0.072 | Aromatase inhibitor | |||
| 0.085 | 0.046 | 0.117 | Na+ K+ transporting ATPase inhibitor | 0.117 0.018 CID_154699618 | CID_154699618 | |
| 0.073 | 0.034 | 0.073 | NMDA receptor agonist | |||
| 0.062 | 0.024 | 0.123 | Carbonic anhydrase XIV inhibitor | 0.123 0.007 CID_154699618 | CID_154699618 | |
| 0.063 | 0.027 | 0.063 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.069 | 0.033 | 0.084 | Carbonic anhydrase IX inhibitor | 0.084 0.025 CID_154699618 | CID_154699618 | |
| 0.067 | 0.031 | 0.067 | Carbonic anhydrase II inhibitor | 0.056 0.038 CID_154699618 | ||
| 0.055 | 0.02 | 0.055 | Glutamate (mGluR group III) agonist | |||
| 0.069 | 0.034 | 0.069 | NMDA 2C receptor antagonist | |||
| 0.149 | 0.115 | 0.153 | Anesthetic general | 0.153 0.11 CID_154699618 | CID_154699618 | |
| 0.046 | 0.013 | 0.046 | VCAM-1 antagonist | |||
| 0.046 | 0.013 | 0.046 | VCAM antagonist | |||
| 0.055 | 0.022 | 0.055 | NMDA receptor subunit 3B antagonist | |||
| 0.115 | 0.083 | 0.115 | M17 leucyl aminopeptidase inhibitor | |||
| 0.06 | 0.028 | 0.06 | Autotaxin inhibitor | |||
| 0.204 | 0.173 | 0.63 | Antithrombotic | 0.63 0.013 CID_154699618 | CID_154699618 | |
| 0.064 | 0.034 | 0.064 | Argininosuccinate synthase inhibitor | |||
| 0.094 | 0.064 | 0.094 | DNA directed RNA polymerase inhibitor | |||
| 0.045 | 0.015 | 0.045 | Estrogen-related receptor alpha antagonist | |||
| 0.187 | 0.158 | 0.187 | Transcription factor STAT inhibitor | |||
| 0.031 | 0.003 | 0.031 | Glutamate (mGluR6) agonist | |||
| 0.048 | 0.021 | 0.048 | NMDA receptor subunit 3A antagonist | |||
| 0.072 | 0.044 | 0.072 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.071 | 0.044 | 0.071 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.035 | 0.009 | 0.035 | Thyroid hormone agonist | |||
| 0.063 | 0.036 | 0.063 | Glutamate (mGluR1) antagonist | |||
| 0.028 | 0.003 | 0.028 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.016 0.008 CID_154699618 | ||
| 0.146 | 0.121 | 0.146 | Interleukin antagonist | |||
| 0.073 | 0.047 | 0.073 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.057 | 0.032 | 0.057 | Thromboxane synthase inhibitor | |||
| 0.087 | 0.062 | 0.148 | NADH dehydrogenase inhibitor | 0.148 0.018 CID_154699618 | CID_154699618 | |
| 0.094 | 0.07 | 0.094 | Nitric-oxide synthase inhibitor | |||
| 0.033 | 0.01 | 0.033 | Estrogen-related receptor gamma antagonist | |||
| 0.059 | 0.036 | 0.059 | Carbonic anhydrase I inhibitor | 0.05 0.043 CID_154699618 | ||
| 0.057 | 0.034 | 0.111 | Carbonic anhydrase XII inhibitor | 0.111 0.018 CID_154699618 | CID_154699618 | |
| 0.102 | 0.08 | 0.102 | Anesthetic local | |||
| 0.096 | 0.075 | 0.096 | Ferrochelatase inhibitor | |||
| 0.075 | 0.054 | 0.119 | Carbonic anhydrase XIII inhibitor | 0.119 0.03 CID_154699618 | CID_154699618 | |
| 0.203 | 0.183 | 0.203 | Beta lactamase inhibitor | |||
| 0.053 | 0.033 | 0.053 | Thromboxane A2 antagonist | |||
| 0.064 | 0.044 | 0.112 | Neuraminidase (influenza) inhibitor | 0.112 0.013 CID_154699618 | CID_154699618 | |
| 0.113 | 0.094 | 0.113 | Toll-Like receptor 9 antagonist | |||
| 0.095 | 0.075 | 0.095 | Carbonic anhydrase XV inhibitor | |||
| 0.054 | 0.034 | 0.054 | NMDA 2A receptor antagonist | |||
| 0.037 | 0.019 | 0.037 | Glutamate (mGluR4) agonist | |||
| 0.059 | 0.04 | 0.059 | Ryanodine receptor antagonist | |||
| 0.152 | 0.134 | 0.152 | Dyrk kinase inhibitor | |||
| 0.033 | 0.015 | 0.033 | Elastase 2B inhibitor | |||
| 0.033 | 0.015 | 0.033 | Elastase 3B inhibitor | |||
| 0.033 | 0.015 | 0.033 | Elastase 3A inhibitor | |||
| 0.093 | 0.075 | 0.093 | GABA C receptor agonist | |||
| 0.075 | 0.058 | 0.075 | Macrophage migration inhibitory factor inhibitor | |||
| 0.031 | 0.015 | 0.031 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.052 | 0.037 | 0.052 | Vanilloid 2 antagonist | |||
| 0.058 | 0.043 | 0.058 | Androgen agonist | |||
| 0.038 | 0.024 | 0.038 | Integrin alpha2 antagonist | |||
| 0.023 | 0.009 | 0.023 | Retinoid X beta receptor antagonist | |||
| 0.043 | 0.029 | 0.043 | Nerve growth factor antagonist | |||
| 0.028 | 0.014 | 0.028 | NMDA receptor glycine site antagonist | |||
| 0.03 | 0.016 | 0.03 | NMDA 2D receptor antagonist | |||
| 0.045 | 0.031 | 0.045 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.117 | 0.104 | 0.289 | Cell wall synthesis inhibitor | 0.289 0.01 CID_154699618 | CID_154699618 | |
| 0.05 | 0.038 | 0.105 | Glucose-6-phosphate translocase inhibitor | 0.105 0.005 CID_154699618 | CID_154699618 | |
| 0.049 | 0.037 | 0.049 | Potassium channel (Inward rectifier) activator | |||
| 0.049 | 0.038 | 0.049 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.062 | 0.051 | 0.062 | Beta adrenoreceptor antagonist | |||
| 0.047 | 0.036 | 0.047 | Potassium channel (ATP-sensitive) activator | |||
| 0.067 | 0.057 | 0.067 | Catalase inhibitor | |||
| 0.077 | 0.067 | 0.077 | Calcium antagonist | |||
| 0.054 | 0.044 | 0.074 | Adenine nucleotide translocase inhibitor | 0.074 0.012 CID_154699618 | CID_154699618 | |
| 0.037 | 0.028 | 0.037 | Retinoid X receptor antagonist | |||
| 0.018 | 0.009 | 0.018 | Thyroid hormone alpha agonist | |||
| 0.05 | 0.042 | 0.05 | Thromboxane antagonist | |||
| 0.01 | 0.003 | 0.01 | Insulin like growth factor 3 antagonist | 0.006 0.005 CID_154699618 | ||
| 0.017 | 0.01 | 0.017 | Thyroid hormone alpha antagonist | |||
| 0.094 | 0.087 | 0.113 | Mucolytic | 0.113 0.061 CID_154699618 | CID_154699618 | |
| 0.014 | 0.008 | 0.014 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.105 | 0.098 | 0.105 | Cyclooxygenase 2 inhibitor | |||
| 0.153 | 0.147 | 0.32 | Cyclic AMP phosphodiesterase inhibitor | 0.32 0.034 CID_154699618 | CID_154699618 | |
| 0.109 | 0.103 | 0.109 | Toll-Like receptor antagonist | |||
| 0.037 | 0.032 | 0.037 | Dopamine D5 agonist | |||
| 0.009 | 0.005 | 0.009 | Thyroid hormone beta agonist | |||
| 0.018 | 0.015 | 0.018 | 5-Alpha-reductase 2 inhibitor | |||
| 0.069 | 0.067 | 0.069 | Keratolytic | |||
| 0.031 | 0.029 | 0.031 | Retinoid X alpha receptor antagonist | |||
| 0.061 | 0.059 | 0.061 | Potassium channel (ATP-sensitive) blocker | |||
| 0.022 | 0.02 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.044 | 0.042 | 0.059 | Glucose-6-phosphate isomerase inhibitor | 0.059 0.019 CID_154699618 | CID_154699618 | |
| 0.061 | 0.059 | 0.061 | Carbonic anhydrase VA inhibitor | |||
| 0.033 | 0.031 | 0.033 | 5-Alpha-reductase inhibitor | |||
| 0.063 | 0.062 | 0.063 | Exportin-1 inhibitor | |||
| 0.009 | 0.008 | 0.009 | Progesterone receptor A antagonist | |||
| 0.018 | 0.017 | 0.018 | Progesterone receptor B antagonist | |||
| 0.023 | 0.024 | 0.039 | Vanilloid 2 agonist | 0.039 0.004 CID_154699618 | CID_154699618 | |
| 0.039 | 0.043 | 0.056 | Estrogen agonist | 0.056 0.032 CID_154699618 | CID_154699618 | |
| 0.03 | 0.038 | 0.032 | Protein kinase C beta I inhibitor | 0.032 0.03 CID_154699618 | CID_154699618 | |
| 0.165 | 0.176 | 0.325 | DNA synthesis inhibitor | 0.325 0.036 CID_154699618 | CID_154699618 | |
| 0.016 | 0.036 | 0.024 | Dopamine D1 agonist | 0.024 0.014 CID_154699618 | CID_154699618 | |
| 0.011 | 0.04 | 0.016 | Telomerase stimulant | 0.016 0.014 CID_154699618 | CID_154699618 | |
| 0.09 | 0.12 | 0.248 | Cyclooxygenase 3 inhibitor | 0.248 0.009 CID_154699618 | CID_154699618 | |
| 0.081 | 0.112 | 0.168 | Toll-Like receptor 4 antagonist | 0.168 0.013 CID_154699618 | CID_154699618 | |
| 0.04 | 0.071 | 0.055 | Leukotriene B4 antagonist | 0.055 0.035 CID_154699618 | CID_154699618 | |
| 0.072 | 0.106 | 0.093 | T cell inhibitor | 0.093 0.032 CID_154699618 | CID_154699618 | |
| 0.073 | 0.108 | 0.273 | Expectorant | 0.273 0.01 CID_154699618 | CID_154699618 | |
| 0.039 | 0.075 | 0.089 | Neuraminidase inhibitor | 0.089 0.02 CID_154699618 | CID_154699618 | |
| 0.03 | 0.066 | 0.079 | Mannosidase inhibitor | 0.079 0.009 CID_154699618 | CID_154699618 | |
| 0.016 | 0.052 | 0.078 | Sodium/glucose cotransporter 2 inhibitor | 0.078 0.004 CID_154699618 | CID_154699618 | |
| 0.06 | 0.098 | 0.094 | Glycine receptor antagonist | 0.094 0.038 CID_154699618 | CID_154699618 | |
| 0.012 | 0.056 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.007 CID_154699618 | CID_154699618 | |
| 0.023 | 0.077 | 0.075 | Phosphorylase inhibitor | 0.075 0.018 CID_154699618 | CID_154699618 | |
| 0.034 | 0.091 | 0.073 | Alpha-mannosidase inhibitor | 0.073 0.015 CID_154699618 | CID_154699618 | |
| 0.124 | 0.182 | 0.446 | Immunostimulant | 0.446 0.038 CID_154699618 | CID_154699618 | |
| 0.015 | 0.075 | 0.057 | Sodium/glucose cotransporter inhibitor | 0.057 0.004 CID_154699618 | CID_154699618 | |
| 0.109 | 0.175 | 0.417 | Hepatoprotectant | 0.417 0.012 CID_154699618 | CID_154699618 | |
| 0.035 | 0.102 | 0.102 | Heparanase inhibitor | 0.102 0.004 CID_154699618 | CID_154699618 | |
| 0.009 | 0.08 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.014 CID_154699618 | CID_154699618 | |
| 0.068 | 0.144 | 0.2 | AMP-activated protein kinase stimulant | 0.2 0.011 CID_154699618 | CID_154699618 | |
| 0.071 | 0.15 | 0.107 | Phosphodiesterase 6D inhibitor | 0.107 0.039 CID_154699618 | CID_154699618 | |
| 0.052 | 0.144 | 0.154 | Mediator release inhibitor | 0.154 0.027 CID_154699618 | CID_154699618 | |
| 0.114 | 0.208 | 0.237 | Spasmolytic | 0.237 0.097 CID_154699618 | CID_154699618 | |
| 0.107 | 0.213 | 0.146 | CC chemokine 6 receptor antagonist | 0.146 0.028 CID_154699618 | CID_154699618 | |
| 0.09 | 0.197 | 0.388 | Platelet adhesion inhibitor | 0.388 0.013 CID_154699618 | CID_154699618 | |
| 0.028 | 0.136 | 0.18 | Antineoplastic antibiotic | 0.18 0.025 CID_154699618 | CID_154699618 | |
| 0.068 | 0.18 | 0.304 | Thrombolytic | 0.304 0.023 CID_154699618 | CID_154699618 | |
| 0.034 | 0.165 | 0.141 | Topoisomerase II alpha inhibitor | 0.141 0.025 CID_154699618 | CID_154699618 | |
| 0.021 | 0.167 | 0.043 | Microtubule stabilization | 0.043 0.037 CID_154699618 | CID_154699618 | |
| 0.034 | 0.182 | 0.092 | Histone deacetylase stimulant | 0.092 0.033 CID_154699618 | CID_154699618 | |
| 0.034 | 0.182 | 0.092 | Histone deacetylase SIRT1 stimulant | 0.092 0.033 CID_154699618 | CID_154699618 | |
| 0.021 | 0.177 | 0.34 | Selectin antagonist | 0.34 0.004 CID_154699618 | CID_154699618 | |
| 0.071 | 0.227 | 0.167 | Diuretic | 0.167 0.063 CID_154699618 | CID_154699618 | |
| 0.042 | 0.208 | 0.212 | Topoisomerase II inhibitor | 0.212 0.031 CID_154699618 | CID_154699618 | |
| 0.017 | 0.203 | 0.097 | Protein 50S ribosomal subunit inhibitor | 0.097 0.014 CID_154699618 | CID_154699618 | |
| 0.048 | 0.248 | 0.127 | Transcription factor NF kappa B stimulant | 0.127 0.022 CID_154699618 | CID_154699618 | |
| 0.008 | 0.208 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.024 CID_154699618 | CID_154699618 | |
| 0.029 | 0.237 | 0.197 | Topoisomerase I inhibitor | 0.197 0.027 CID_154699618 | CID_154699618 | |
| 0.008 | 0.235 | 0.044 | Protein 30S ribosomal subunit inhibitor | 0.044 0.009 CID_154699618 | CID_154699618 | |
| 0.032 | 0.266 | 0.113 | DNA intercalator | 0.113 0.062 CID_154699618 | CID_154699618 | |
| 0.032 | 0.339 | 0.058 | Lipocortins synthesis agonist | 0.058 0.039 CID_154699618 | CID_154699618 | |
| 0.057 | 0.37 | 0.222 | Hemostatic | 0.222 0.026 CID_154699618 | CID_154699618 | |
| 0.046 | 0.369 | 0.191 | Hypolipemic | 0.191 0.101 CID_154699618 | CID_154699618 | |
| 0.114 | 0.491 | 0.668 | Antiinflammatory | 0.668 0.037 CID_154699618 | CID_154699618 | |
| 0.045 | 0.437 | 0.344 | Tumour necrosis factor alpha release inhibitor | 0.344 0.039 CID_154699618 | CID_154699618 | |
| 0.052 | 0.485 | 0.436 | Immunosuppressant | 0.436 0.051 CID_154699618 | CID_154699618 | |
| 0.017 | 0.457 | 0.066 | Factor IXa inhibitor | 0.066 0.023 CID_154699618 | CID_154699618 | |
| 0.017 | 0.483 | 0.092 | Cell adhesion molecule inhibitor | 0.092 0.04 CID_154699618 | CID_154699618 | |
| 0.012 | 0.494 | 0.068 | Antibiotic Aminoglycoside-like | 0.068 0.006 CID_154699618 | CID_154699618 | |
| 0.023 | 0.562 | 0.181 | Cell adhesion inhibitor | 0.181 0.03 CID_154699618 | CID_154699618 | |
| 0.009 | 0.633 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.015 CID_154699618 | CID_154699618 | |
| 0.035 | 0.7 | 0.643 | Cyclophilin D inhibitor | 0.643 0.021 CID_154699618 | CID_154699618 | |
| 0.011 | 0.693 | 0.202 | Platelet antagonist | 0.202 0.099 CID_154699618 | CID_154699618 | |
| 0.013 | 0.752 | 0.171 | Insulin secretagoues | 0.171 0.055 CID_154699618 | CID_154699618 | |
| 0.005 | 0.896 | 0.124 | Anticoagulant | 0.124 0.108 CID_154699618 | CID_154699618 | |
| 0.008 | 0.921 | 0.201 | Immunomodulator | 0.201 0.163 CID_154699618 | CID_154699618 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |